BIOSGN fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Biosergen AB operates as a biopharmaceutical company. It focuses on the clinical development of the antifungal product BSG005, is a potentially disruptive antifungal drug used for the treatment of life threatening invasive fungal disease. The company is headquartered in Solna, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
BIOSGN does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company